Cognitive
NA-Selank-Amidate
Also called N-Acetyl Selank Amidate
per administration
The amounts going around come from sellers and forums, not from any study.
The human evidence for NA-Selank-Amidate used the intranasal route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Quick start
NA-Selank-Amidate at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 100–300 mcg per administration
- How often
- Every day
- Where
- Intranasal spray
- Time to steady level
- ~5 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for NA-Selank-Amidate describe 100–300 mcg per administration. Descriptive only, not a recommendation.
The N-terminal acetyl and C-terminal amide slow peptidase degradation relative to Selank, but human pharmacokinetics are essentially unpublished, so read this as order-of-magnitude only.
A terminally modified Selank analog. Circulating amounts come from vendor listings and community write-ups rather than any published dose-ranging work, and no human trial of its own fixes an amount or schedule, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 5hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Modified-Selank / neuropeptide community literatureThe N-acetyl amidated analog has no published human dose-ranging trial; figures trace to vendor listings and community reports.